The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I imagine that there will be ongoing production and ramping up of Affimer and LFD's in parallel to support the initial roll out of the mass screening programme.
Imagine the (further) egg on face for Government if they announce the roll out only to say we've run out... there will be huge demand for the product ongoing, but there will be an initial surge to get initial stocks out to the retailers and resellers and into the clinical environments to enable the programme to launch. Once launched the production will continue and likely grow to support the unfulfilled wider global demand (outside of UK which will be first).
I simply cannot see that this is dead time. Frustrating yes, (in the context of expecting to be further ahead that it seems we are) but I'm pretty confident the ancient art of thumb twiddling is not going on in Avacta towers.
Ah, OK, yes I saw that discussion. To be honest my message was probably rather mixed in it's own right!
The question of "Is this us?" was more to the clinical trial link... Or is this for the pretty inaccurate test linked in your last message?
Further, then, what was the purpose of the original post here? I thought you were highlighting new info on the MedUSA19 page?
TIA
Is this us? Where's the trial/validation at for this as long past due from the dates in the link.
Must say that MedUSA19 could do with providing some more clarity on their test offerings. The Rapid Saliva Protein Test (RSPT) sounds very much like Antigen but isn't. How would a lay person know what they were even buying?
The blood finger prick LFT is ODX? Which as you say is Antibody test.
This is a superb find, well done Wiggly. There is no other test meeting the criteria. Looks like the market is waking up to this a little more nudging £1.70 now...
Likewise, can sell any amount at £1.43 but can't buy a bean
Exactly, you may need to give your head a wobble if you think CF would RNS that we signed an internal contract!
Bought yesterday - reported as sell
Bought today - reported as sell
Take a look at the the buys v's sells and they weight on the buy side heavily over the last few days - add in the mis-reported buys as sells and it's even stronger. Games are being played and I'm not giving any of my tokens away, but buying more whilst the opportunity presents itself...
I know there's some dubiety over the reporting (and my buy today reported as a sell), but just look at the volumes...
Vol. Sold 838,426
Sold Value £1m
Vol. Bought 1,593,130
Bought Value £3m
I've topped up (again) secured 161p, but only with a "sensible" value on top of what I already hold. I did however try a dummy buy for 60k shares, and they were offered at 161.2p which surprised me. Needless to say I've not got the same balls as Banjo to lump such funds in at this time on top of current holdings but shares are available. Anyway, thanks for the cheap share, onwards and upwards!
Been buying in since 80's, to hold for the ride, in both ISA and SIPP, but now also bought some more to trade / short term profit taking on the roller coaster in my trading account.
Look at your contract notes, for what you ACTUALLY paid, it may well be that the summary of "Cost" is incorrect. I imagine the calculation is off somewhere by not using a true weighted average of your buy prices but perhaps simple buy prices not taking in to account you held 93% of your holdings at an average of £1.46. If your contract notes add up to the correct value paid then I wouldn't worry about having been ripped off!
I'm not knocking your rationale or basis for valuation, more suggesting that if you believe 5 x revenue, then you should review your calc again as you actually assumed Income(profit) i.e. £1 x 5 to reach your valuation.
5 x Revenue or 5 x Income? You said Rdv but used Income in your calc...
25p profit per test?!
We would need to be "well in profit" as not just this years result as a stand alone so we need to clear the cumulative losses first before dividends can be declared so that's best part of 7m before we turn to positive territory to be legally able to pay a dividend. I should know this but what level of net profit are we to expect this year (putting yo one side the like of Luxe and AdB as these are unknowns - hopefully good unknowns!)
Yes I would agree, so my thinking was the big loss reported last year put them back but if this year brings them back into the black they could be payable but if this hurdle is stopping them I'm not sure there'll be much scope even if they have the cash at their disposal.
I'm all for dividends but from a technical point of view are they in a position to legally pay dividends? Thinking along the lines that you can ONLY pay dividends from retained net profits and looking at the Dec18 BS they have retained earnings of (6.87)m so retained loss does this constrain the option to pay until positive net profit/retained earning are reported? Having cash is one thing but dividends can only be paid from profits. I may be wrong but thought I'd put this potential explanation out there for discussion.
I think the last one was over subscribed and company allowed shsteholders to sell more than the allotted number at their discretion in the end.
I recall buying the x% I could sell based on holding prior and then tendered same number and locked in a guaranteed profit. No massive but having been in for longer thsn I can remember I saw the opportunity and deserved it!
Sunday, any reply from Mr H to your email enquiries last week? If so anything you can share?
I'll happily email him (as I have done before), but see little point in bombarding him with emails asking the same questions. If he's replied but you can't share I'll email him myself.
Has anyone got any domains from the MMX stable? If so did you buy to use or plan to gain from their resale? If resale have you had success?
I have a few bought for investment/resale but not done anything with them as yet.